Works matching IS 02698811 AND DT 2015 AND VI 29 AND IP 1

Results: 9

Safety and tolerability of atomoxetine in treatment of attention deficit hyperactivity disorder in adult patients: An integrated analysis of 15 clinical trials.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 1, p. 3, doi. 10.1177/0269881114560183

By:

Camporeale, Angelo;
Porsdal, Vibeke;
De Bruyckere, Katrien;
Tanaka, Yoko;
Upadhyaya, Himanshu;
Deix, Claudia;
Deberdt, Walter

Publication type:

Article

A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 1, p. 50, doi. 10.1177/0269881114560182

By:

Mahoney, James J;
Thompson-Lake, Daisy GY;
Cooper, Kimberly;
Verrico, Christopher D;
Newton, Thomas F;
De La Garza, Richard

Publication type:

Article

Multi-level biomarker analysis of nitric oxide synthase isoforms in bipolar disorder and adult ADHD.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 1, p. 31, doi. 10.1177/0269881114555251

By:

Kittel-Schneider, Sarah;
Reuß, Martin;
Meyer, Andrea;
Weber, Heike;
Gessner, Alexandra;
Leistner, Carolin;
Kopf, Juliane;
Schmidt, Brigitte;
Hempel, Susanne;
Volkert, Julia;
Lesch, Klaus-Peter;
Reif, Andreas

Publication type:

Article

LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 1, p. 57, doi. 10.1177/0269881114555249

By:

Gasser, Peter;
Kirchner, Katharina;
Passie, Torsten

Publication type:

Article

Considerations on the role of buprenorphine in recovery from heroin addiction from a UK perspective.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 1, p. 43, doi. 10.1177/0269881114555248

By:

Nutt, David J

Publication type:

Article

Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: A randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trial.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 1, p. 69, doi. 10.1177/0269881114553253

By:

Laties, Alan M;
Flach, Allan J;
Baldycheva, Irina;
Rak, Ihor;
Earley, Willie;
Pathak, Sanjeev

Publication type:

Article

Services for young people with attention deficit/hyperactivity disorder transitioning from child to adult mental health services: A national survey of mental health trusts in England.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 1, p. 39, doi. 10.1177/0269881114550353

By:

Hall, Charlotte L;
Newell, Karen;
Taylor, John;
Sayal, Kapil;
Hollis, Chris

Publication type:

Article

Predicting methylphenidate response in attention deficit hyperactivity disorder: A preliminary study.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 1, p. 24, doi. 10.1177/0269881114548438

By:

Johnston, Blair A;
Coghill, David;
Matthews, Keith;
Steele, J Douglas

Publication type:

Article

Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 1, p. 15, doi. 10.1177/0269881114544777

By:

Cunill, R;
Castells, X;
Tobias, A;
Capellà, D

Publication type:

Article